Translating B Cell Epitope Peptide Based Cancer Vaccines to the Clinic - Immunotherapies

Explore a 33-minute webinar presented by Dr. Linlin Guo, a post-doctoral fellow and Senior Researcher at The Ohio State University Wexner Medical Center, on translating B cell epitope peptide-based cancer vaccines to clinical immunotherapies. Learn about the limitations of current checkpoint inhibitors and HER-2 inhibitors, and discover a novel PD-L1 B-cell peptide vaccine linked to T cell peptides. Gain insights into ongoing clinical studies and the potential of combination immuno-oncology agents to improve patient outcomes in cancer treatment.

Translating B Cell Epitope Peptide Based Cancer Vaccines to the Clinic Immunotherapies